Literature DB >> 27098266

Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis.

Michelle Price1, Albrecht Günther, Joseph S K Kwan.   

Abstract

BACKGROUND: Intracranial venous thrombosis (ICVT) commonly presents with seizures in the acute period, and some people may develop recurrent seizures in the long term. The prophylactic use of antiepileptic drugs (AEDs) for the management of post-ICVT seizures is controversial, and there is currently no consensus on the optimal management of post-ICVT seizures. This is an updated version of the Cochrane review first published in theCochrane Database of Systematic Reviews 2006, Issue 3.
OBJECTIVES: To assess the effects of AEDs for the primary and secondary prevention of seizures related to ICVT.(1) For the question of primary prevention, we aimed to examine whether AEDs reduce the likelihood of seizures in people who have had an ICVT but have not had a seizure.(2) For the question of secondary prevention, we aimed to examine whether AEDs reduce the likelihood of further seizures in people who have had an ICVT and at least one seizure. SEARCH
METHODS: For the latest update, we searched the Cochrane Epilepsy Group Specialized Register, the Cochrane Central Register of Controlled Trials (CENTRAL) via the Cochrane Register of Studies Online (CRSO), and MEDLINE (Ovid 1946 onwards) to 20 April 2015, and we checked the reference lists of articles retrieved from the searches. SELECTION CRITERIA: We planned to include all randomised and quasi-randomised controlled trials in which participants with a diagnosis of ICVT were assigned to a treatment group (that is, receiving at least one AED) or control group (receiving placebo or no drug). DATA COLLECTION AND ANALYSIS: Both review authors independently screened and assessed the methodological quality of the studies. If studies had been included in the review, one review author would have extracted the data and another would have checked the extracted data. MAIN
RESULTS: No relevant studies were found. AUTHORS'
CONCLUSIONS: There is no evidence to support or refute the use of antiepileptic drugs for the primary or secondary prevention of seizures related to intracranial venous thrombosis. Well-designed randomised controlled trials are urgently needed to inform practice. Since the last version of this review no new studies have been found.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27098266      PMCID: PMC7265129          DOI: 10.1002/14651858.CD005501.pub4

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  22 in total

Review 1.  Anticoagulation for cerebral venous sinus thrombosis.

Authors:  Jonathan Coutinho; Sebastiaan Ftm de Bruijn; Gabrielle Deveber; Jan Stam
Journal:  Cochrane Database Syst Rev       Date:  2011-08-10

2.  Lumbar puncture and dural sinus thrombosis--a causal or casual association?

Authors:  Patrícia Canhão; Paulo Batista; Filipa Falcão
Journal:  Cerebrovasc Dis       Date:  2004-11-03       Impact factor: 2.762

3.  Cerebral venous and sinus thrombosis - an update.

Authors:  K M Einhäupl; F Masuhr
Journal:  Eur J Neurol       Date:  1994-11       Impact factor: 6.089

Review 4.  The spectrum of presentations of venous infarction caused by deep cerebral vein thrombosis.

Authors:  Walter M van den Bergh; Irene van der Schaaf; Jan van Gijn
Journal:  Neurology       Date:  2005-07-26       Impact factor: 9.910

5.  Causes and predictors of death in cerebral venous thrombosis.

Authors:  Patrícia Canhão; José M Ferro; Arne G Lindgren; Marie-Germaine Bousser; Jan Stam; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2005-07-07       Impact factor: 7.914

6.  Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. For The Cerebral Venous Sinus Thrombosis Study Group.

Authors:  S F de Bruijn; R J de Haan; J Stam
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

7.  Cerebral venous thrombosis: an all or nothing disease? Prognostic factors and long-term outcome.

Authors:  Erwin Stolz; Anousha Rahimi; Tibo Gerriets; Jörg Kraus; Manfred Kaps
Journal:  Clin Neurol Neurosurg       Date:  2005-02       Impact factor: 1.876

8.  Cerebral venous thrombosis in children: a multifactorial origin.

Authors:  Christine Heller; Achim Heinecke; Ralf Junker; Ralf Knöfler; Andrea Kosch; Karin Kurnik; Rosemarie Schobess; Arnold von Eckardstein; Ronald Sträter; Barbara Zieger; Ulrike Nowak-Göttl
Journal:  Circulation       Date:  2003-08-25       Impact factor: 29.690

Review 9.  Cerebral venous and sinus thrombosis.

Authors:  F Masuhr; S Mehraein; K Einhäupl
Journal:  J Neurol       Date:  2004-01       Impact factor: 4.849

Review 10.  Magnetic resonance imaging of cerebral venous sinus thrombosis.

Authors:  S E J Connor; J M Jarosz
Journal:  Clin Radiol       Date:  2002-06       Impact factor: 2.350

View more
  3 in total

1.  Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysis.

Authors:  Oliver Enke; Heather A New; Charles H New; Stephanie Mathieson; Andrew J McLachlan; Jane Latimer; Christopher G Maher; C-W Christine Lin
Journal:  CMAJ       Date:  2018-07-03       Impact factor: 8.262

Review 2.  Seizures and epilepsy in patients with ischaemic stroke.

Authors:  Johann Philipp Zöllner; Friedhelm C Schmitt; Felix Rosenow; Konstantin Kohlhase; Alexander Seiler; Adam Strzelczyk; Hermann Stefan
Journal:  Neurol Res Pract       Date:  2021-12-06

Review 3.  Seizure in cerebral venous and sinus thrombosis.

Authors:  Jafar Mehvari Habibabadi; Mohammad Saadatnia; Nasim Tabrizi
Journal:  Epilepsia Open       Date:  2018-06-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.